The new paper reveals for the first time that these DNA fragments can persist in cancer cells and may drive relapse in patients with...

Chemotherapy resistance is particularly common in what is known as T-ALL, a subtype of ALL. This recent study shows that the origin of...

As we age, some populations of immune cells change in abundance and these changes can be measured and used to infer one’s immunological...

Planned caesarean births—"C-sections"—slightly raise the risk of some childhood cancers—particularly acute lymphoblastic leukemia (ALL),...

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development at which...

Investigators have discovered how NUP98-fusion proteins drive pediatric acute myeloid leukemia, identifying novel single-agent and...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukaemia...

New research on children diagnosed with acute lymphoblastic leukemia (ALL) shows that the longer a patient’s body mass index (BMI) falls...

The Leukemia & Lymphoma Society (LLS) announced today the first pediatric patient has received treatment in a new subtrial of its...

Asparaginase (ASNase) remains a cornerstone of chemo regimens for ALL. But there’s a quiet threat that’s often missed: hypersensitivity...